Wegovy (semaglutide 2.4 mg) is a newer medication, receiving MHRA marketing authorisation for weight management
SURPASS-4: long-term safety data SURPASS-4 extended the evidence to 104 weeks, two full years, in patients with type 2 diabetes inadequately controlled on metformin and/or sulfonylureas
Check pH with strips or a calibrated meter
To get more updates on this particular weight loss journey, pictures of the food I eat, and my entire catalogue of weight loss information, articles, mindset advice, experience, strategies, and tips/tricks that I have gathered and published over the years click here.
BPC-157 is typically reconstituted using sterile bacteriostatic water for multi-dose stability, or sterile water for injection for single-use preparations